Skip to main content

Adria Molero Valenzuela

I am a pre-doctoral researcher in the research group Childhood Cancer and Hematological Diseases and specifically I work on the development of RNA-based therapies for the treatment of Hepatoblastoma, the most common liver tumor in children and adolescents.

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Adria Molero Valenzuela

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

I am a pre-doctoral researcher in the research group Childhood Cancer and Hematological Diseases and specifically I work on the development of RNA-based therapies for the treatment of Hepatoblastoma, the most common liver tumor in children and adolescents.

I graduated in Biology at the University of Barcelona (UB) doing my final thesis at the Department of Hereditary Cancer of IDIBELL and then I did my master's degree in Biomedicine, also at the UB, where I did my final thesis at the Laboratory of Molecular Biology in Cancer of the Faculty of Medicine of Bellvitge. Currently, I am starting my PhD in Biochemistry, Molecular Biology and Biomedicine.

Projects

Development of prognostic and therapeutic tools targeting epigenetic regulators in metastatic neuroblastoma

IP: Miguel Segura Ginard
Collaborators: María Rosario Pérez- Torres Lobato, Maria Jose Pérez García, Lorena Valero Arrese, Development of prognostic and therapeutic tools targeting epigenetic regulators in metastatic neuroblastoma, Adria Molero Valenzuela, Khloud Abdo Soliman Elsharawy
Funding agency: Instituto de Salud Carlos III
Funding: 315000
Reference: PI23/01144
Duration: 01/01/2024 - 31/12/2026

Desenvolupament de fàrmacs per inhibir la funció del complexe remodelador de la cromatina BAF.

IP: Miguel Segura Ginard
Collaborators: Adria Molero Valenzuela
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2021 LLAV 00002
Duration: 12/10/2022 - 11/07/2023

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Elisabet Megías Roda, Raquel Hladun Alvaro, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

Related news

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Related professionals

Vicenta Pujol Blaya

Vicenta Pujol Blaya

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Cristina Salon Ajenjo

Cristina Salon Ajenjo

Read more
Juan A. Porcel Vázquez

Juan A. Porcel Vázquez

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Marina Hortola Bufi

Marina Hortola Bufi

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.